Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to ...

Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

Weight-loss drug developer Metsera is targeting an up to $1.78 billion valuation in its initial public offering, the ARCH Venture Partners-backed biotech company said on Monday. New York City-based ...

Now, Shift, a new social venture founded by Dutch entrepreneur ... Supported by a network of Dutch strategic partners and impact financiers, the first Shift landmark will be in the Netherlands ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

Markowitz, meanwhile, has joined Regeneron Ventures after a three-year stint at ARCH Venture Partners, where he was a senior partner and founded three companies, also serving as a board member and ...

Highstreet Insurance Partners ("Highstreet"), one of the fastest growing community-based insurance brokerages and financial service firms in the US, announced today its acquisition of Siebert Agency ...

A joint venture between Elliott Investment Management and Trinity Investments secured an $800 million loan in connection with ...

The award of the SEZ License designates Giyani's Commercial Plant as a Single Factory Special Economic Zone. The Commercial Plant will be located adjacent to its K.Hill manganese mine site, near Kanye ...

The drone industry – both consumer and industrial – has made incredible strides over the past decade, but in my humble ...